CLINICAL_TRIALS trial_result · 2025-06-08

Clinical Trial Update: A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Novo Nordisk’s NNC0385-0434 tablets for lowering blood cholesterol in people with atherosclerotic cardiovascular disease or at high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Atherosclerotic Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-06-08